Re-Mind uses Lithium Orotate, which is highlighted for its improved brain uptake compared to traditional lithium salts. Pre-clinical data suggests that lithium orotate may avoid sequestration by amyloid plaques, potentially leading to better brain availability. This low-dose strategy aims to minimize side effects associated with high-dose lithium prescriptions.